ADDvise receives breakthrough order worth 3,3 MSEK

ADDvise Group AB's (publ) subsidiary, Surgical Tables Inc, has received an order worth approximately 3,3 MSEK. In 2017, Surgical Tables launched a collaboration with one of the world's three largest medtech companies to develop a new surgical table for spinal fusion procedures. The purpose of the project was to make the procedures more time efficient and to lower the infection risk. Spinal fusion is a surgical technique that joins two or more vertebrae to eliminate movement and back pain in the patient. 

After six months of clinical evaluation, Surgical Tables has now received an order from one of the world's three largest medtech companies, the same company that has participated in the development project. The order comprises a number of the newly developed tables for spinal fusion. The order value amounts to approximately 3.3 MSEK and delivery will take place during 2018.

 

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se 


Important information:
 

ADDvise Group AB is required to disclose this information under the EU Market Abuse Regulation. The information was submitted for publication on April 30th, 2018 at 09.00 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North and Mangold Fondkommission AB, +46 8 503 015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

About Us

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier. Additional information is available at www.addvisegroup.com.

Subscribe

Documents & Links